• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Recombinant Varicella Zoster vaccine in haemodialysis facilities: adherence and safety
J Nephrol. 2023 Jul 1. doi: 10.1007/s40620-023-01690-0. Online ahead of print.NO ABSTRACTPMID:37392330 | DOI:10.1007/s40620-023-01690-0
Source: Journal of Nephrology - July 1, 2023 Category: Urology & Nephrology Authors: Francesca K Martino Stefano Pini Giuseppe Scaparrotta Marilena Schirinzi Maddalena Gnappi Antonio Fragasso Ruggero Zanella Elena Naso Maria Loreta De Giorgi Gianni Carraro Federico Nalesso Lorenzo A Cal ò Source Type: research

Post-licensure safety study of new-onset immune-mediated diseases, herpes zoster, and anaphylaxis in adult recipients of HepB-CpG vaccine versus HepB-alum vaccine
CONCLUSIONS: This large post-licensure study did not identify evidence of safety concerns for HepB-CpG compared to HepB-alum for immune-mediated diseases, HZ, or anaphylaxis.PMID:37308363 | DOI:10.1016/j.vaccine.2023.06.004
Source: Vaccine - June 12, 2023 Category: Allergy & Immunology Authors: Bradley Ackerson Lina S Sy Jeff Slezak Lei Qian Kristi Reynolds Runxin Huang Zendi Solano William Towner Sijia Qiu Sarah R Simmons Steven J Jacobsen Katia J Bruxvoort Source Type: research

Safety of ChAdOx1 nCoV-19 vaccination in patients with end-stage renal disease on hemodialysis
CONCLUSIONS: Though some ESRD patients on HD had local and systemic AEs after first-dose vaccination, the clinical significance of these symptoms was minor. Our study confirmed the safety profile of ChAdOx1 nCoV-19 in HD patients and presented a new viewpoint on vaccine-related AEs. The SCCS analysis did not find an elevated risk of VAT at 1 month following vaccination. Apart from VAT, other vaccine-related AEs, irrespective of local or systemic symptoms, had minor clinical significance on safety issues. Nonetheless, further coordinated, multi-center, or registry-based studies are needed to establish the causality.PMID:360...
Source: Herpes - September 9, 2022 Category: Infectious Diseases Authors: I-Ning Yang Chin-Li Lu Hung-Jen Tang Yu-Chi Kuo Li-Hwa Tsai Kuan Chieh Tu Jhi-Joung Wang Chih-Chiang Chien Source Type: research

Formulation Optimization and Evaluation of Nanocochleate Gel of Famciclovir for the Treatment of Herpes Zoster
CONCLUSION: A novel nanocochleate gel of Famciclovir was successfully developed for the treatment of infections associated with Herpes Zoster with sustained release action.PMID:35733311 | DOI:10.2174/1872210516666220622115553
Source: Herpes - June 23, 2022 Category: Infectious Diseases Authors: Rahul Sharma Ashwini Deshpande Abhishek Kanugo Source Type: research

Evidence Based Recommendations for Supportive Care in Multiple Myeloma
Conclusion:Along with anti-myeloma chemotherapy therapy, management of complications (anemia, infections, renal insufficiency) and other associated symptoms is necessary to improve the quality of life.DisclosuresNo relevant conflicts of interest to declare.
Source: Blood - November 21, 2018 Category: Hematology Authors: Qureshi, A., Tariq, M. J., Shah, Z., Abu Zar, M., Aslam, S., Rafae, A., Malik, M. N., Kamal, A., Jose, J. A., Selene, I. I., Shafqat, M., Jamil, F., Durer, S., Durer, C., Anwer, F. Tags: 653. Myeloma: Therapy, excluding Transplantation: Poster I Source Type: research